The Serum Institute of India (SII), which manufactures AstraZeneca and Oxford University's Covid-19 vaccine — Covishield, has sought indemnity protection against liabilities, news agency ANI reported citing sources familiar with the matter.
ANI on Wednesday reported that Pfizer and Moderna were a step closer to indemnity deals with the government of India.
The pharma giants had sought from the government indemnity from costs relating to severe vaccine side-effects. India's apex drug regulator has also waived the requirement of testing every batch of foreign-made Covid-19 vaccines and conducting bridging trials for vaccines approved by the WHO.
Published 03 June 2021, 03:09 IST